Journal Article

Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission

Soren Gantt, Rachel Payant, Jacquelyn Carlsson, Mark A. Micek, Ana Judith Blanco, Ingrid A. Beck, Laurinda Matunha, Pablo Montoya, Eduardo Matediana, Stephen Gloyd and Lisa M. Frenkel

in Journal of the Pediatric Infectious Diseases Society

Published on behalf of Pediatric Infectious Diseases Society

Volume 1, issue 3, pages 244-249
Published in print September 2012 | ISSN: 2048-7193
Published online July 2012 | e-ISSN: 2048-7207 | DOI: http://dx.doi.org/10.1093/jpids/pis065
Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Among 30 human immunodeficiency virus type 1 (HIV-1)–infected women who received single-dose nevirapine (NVP), 17 (57%) had NVP-resistant HIV-1 detected in breast milk. NVP resistance in breast milk persisted for at least 8 months postpartum and was apparently transmitted to at least 1 infant. NVP resistance was detected less often in women who also received zidovudine.

Journal Article.  2093 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.